Achilles Therapeutics plc Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SYNCONA PORTFOLIO LTD | 02/06/2025 | 11.09 M | $12.64 M | 0.00% | 27.42% |
BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 4.10 M | $4.67 M | 0.00% | 10.14% |
FCPM III SERVICES B.V. | 02/14/2025 | 2.39 M | $2.75 M | 0.00% | 5.91% |
REDMILE GROUP, LLC | 02/14/2025 | 1.61 M | $1.83 M | 0.00% | 3.98% |
VESTAL POINT CAPITAL, LP | 02/14/2025 | 1.50 M | $1.71 M | 0.00% | 3.71% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 1.44 M | $1.64 M | -0.14% | 3.56% |
SIREN, L.L.C. | 02/14/2025 | 755,375 | $861,128 | 0.00% | 1.87% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 547,233 | $623,846 | -14.24% | 1.35% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 418,441 | $477,023 | -0.49% | 1.04% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 191,829 | $218,000 | -23.52% | 0.47% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 61,637 | $70,266 | 190.07% | 0.15% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 50,189 | $57,215 | 100.00% | 0.12% |
TWO SIGMA ADVISERS, LP | 02/14/2025 | 34,200 | $38,988 | 52.68% | 0.08% |
XTX TOPCO LTD | 02/13/2025 | 26,824 | $30,579 | 100.00% | 0.07% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 21,590 | $24,612 | 0.00% | 0.05% |
BRAVE ASSET MANAGEMENT INC | 01/14/2025 | 10,000 | $11,400 | 0.00% | 0.02% |
RHUMBLINE ADVISERS | 01/30/2025 | 4,480 | $5,106 | 0.00% | 0.01% |
02/06/2025 | 322 | $367 | 100.00% | 0.00% | |
JPMORGAN CHASE & CO | 02/12/2025 | 137 | $156 | 0.00% | 0.00% |
ARCADIA INVESTMENT MANAGEMENT CORP/MI | 02/03/2025 | 0 | $0 | -100.00% | 0.00% |
CORSAIR CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
BAADER BANK AKTIENGESELLSCHAFT | 01/23/2025 | 0 | $0 | -100.00% | 0.00% |
Achilles Therapeutics plc institutional Ownership - FAQ's
During the previous two years, 26 institutional investors and hedge funds held shares of Achilles Therapeutics plc. The most heavily invested institutionals were:
Syncona Portfolio Ltd: 11.09 M
BML Capital Management, LLC: 4.1 M
FCPM III SERVICES B.V.: 2.39 M
Redmile Group, LLC: 1.61 M
Vestal Point Capital, LP: 1.5 M
Ikarian Capital, LLC: 1.44 M
60.10% of Achilles Therapeutics plc stock is owned by institutional investors.
Institutional investors have bought a total of 24.26 M shares in the last 24 months. This purchase volume represents approximately $33.49 M in transactions.